HIV  ||| S:0 E:4 ||| NNP
among  ||| S:4 E:10 ||| IN
men  ||| S:10 E:14 ||| NNS
who  ||| S:14 E:18 ||| WP
have  ||| S:18 E:23 ||| VBP
sex  ||| S:23 E:27 ||| NN
with  ||| S:27 E:32 ||| IN
men  ||| S:32 E:36 ||| NNS
in  ||| S:36 E:39 ||| IN
Malawi ||| S:39 E:45 ||| NNP
:  ||| S:45 E:47 ||| :
elucidating  ||| S:47 E:59 ||| FW
HIV  ||| S:59 E:63 ||| FW
prevalence  ||| S:63 E:74 ||| FW
and  ||| S:74 E:78 ||| CC
correlates  ||| S:78 E:89 ||| NN
of  ||| S:89 E:92 ||| IN
infection  ||| S:92 E:102 ||| NN
to  ||| S:102 E:105 ||| TO
inform  ||| S:105 E:112 ||| VB
HIV  ||| S:112 E:116 ||| NNP
prevention  ||| S:116 E:127 ||| VBD
There  ||| S:127 E:133 ||| EX
are  ||| S:133 E:137 ||| VBP
limited  ||| S:137 E:145 ||| JJ
data  ||| S:145 E:150 ||| NNS
characterizing  ||| S:150 E:165 ||| VBG
the  ||| S:165 E:169 ||| DT
burden  ||| S:169 E:176 ||| NN
of  ||| S:176 E:179 ||| IN
HIV  ||| S:179 E:183 ||| NNP
among  ||| S:183 E:189 ||| IN
men  ||| S:189 E:193 ||| NNS
who  ||| S:193 E:197 ||| WP
have  ||| S:197 E:202 ||| VBP
sex  ||| S:202 E:206 ||| NN
with  ||| S:206 E:211 ||| IN
men  ||| S:211 E:215 ||| NNS
( ||| S:215 E:216 ||| -LRB-
MSM ||| S:216 E:219 ||| NNP
)  ||| S:219 E:221 ||| -RRB-
in  ||| S:221 E:224 ||| IN
Malawi ||| S:224 E:230 ||| NNP
.  ||| S:230 E:232 ||| .
Epidemiologic  ||| S:232 E:246 ||| JJ
research  ||| S:246 E:255 ||| NN
and  ||| S:255 E:259 ||| CC
access  ||| S:259 E:266 ||| NN
to  ||| S:266 E:269 ||| TO
HIV  ||| S:269 E:273 ||| NNP
prevention ||| S:273 E:283 ||| NN
,  ||| S:283 E:285 ||| ,
treatment  ||| S:285 E:295 ||| NN
and  ||| S:295 E:299 ||| CC
care  ||| S:299 E:304 ||| NN
services  ||| S:304 E:313 ||| NNS
have  ||| S:313 E:318 ||| VBP
been  ||| S:318 E:323 ||| VBN
traditionally  ||| S:323 E:337 ||| RB
limited  ||| S:337 E:345 ||| VBN
in  ||| S:345 E:348 ||| IN
Malawi  ||| S:348 E:355 ||| NNP
by  ||| S:355 E:358 ||| IN
criminalization  ||| S:358 E:374 ||| NN
and  ||| S:374 E:378 ||| CC
stigmatization  ||| S:378 E:393 ||| NN
of  ||| S:393 E:396 ||| IN
same-sex  ||| S:396 E:405 ||| JJ
practices ||| S:405 E:414 ||| NNS
.  ||| S:414 E:416 ||| .
To  ||| S:416 E:419 ||| TO
inform  ||| S:419 E:426 ||| VB
the  ||| S:426 E:430 ||| DT
development  ||| S:430 E:442 ||| NN
of  ||| S:442 E:445 ||| IN
a  ||| S:445 E:447 ||| DT
comprehensive  ||| S:447 E:461 ||| JJ
HIV  ||| S:461 E:465 ||| NNP
prevention  ||| S:465 E:476 ||| NN
intervention  ||| S:476 E:489 ||| NN
for  ||| S:489 E:493 ||| IN
Malawian  ||| S:493 E:502 ||| NNP
MSM ||| S:502 E:505 ||| NNP
,  ||| S:505 E:507 ||| ,
we  ||| S:507 E:510 ||| PRP
conducted  ||| S:510 E:520 ||| VBD
a  ||| S:520 E:522 ||| DT
community-led  ||| S:522 E:536 ||| JJ
assessment  ||| S:536 E:547 ||| NN
of  ||| S:547 E:550 ||| IN
HIV  ||| S:550 E:554 ||| NNP
prevalence  ||| S:554 E:565 ||| NN
and  ||| S:565 E:569 ||| CC
correlates  ||| S:569 E:580 ||| NN
of  ||| S:580 E:583 ||| IN
infection ||| S:583 E:592 ||| NN
.  ||| S:592 E:594 ||| .
From  ||| S:594 E:599 ||| IN
April  ||| S:599 E:605 ||| NNP
2011  ||| S:605 E:610 ||| CD
to  ||| S:610 E:613 ||| TO
March  ||| S:613 E:619 ||| NNP
2012 ||| S:619 E:623 ||| CD
,  ||| S:623 E:625 ||| ,
338  ||| S:625 E:629 ||| CD
MSM  ||| S:629 E:633 ||| NNP
were  ||| S:633 E:638 ||| VBD
enrolled  ||| S:638 E:647 ||| VBN
in  ||| S:647 E:650 ||| IN
a  ||| S:650 E:652 ||| DT
cross-sectional  ||| S:652 E:668 ||| JJ
study  ||| S:668 E:674 ||| NN
in  ||| S:674 E:677 ||| IN
Blantyre ||| S:677 E:685 ||| NNP
,  ||| S:685 E:687 ||| ,
Malawi ||| S:687 E:693 ||| NNP
.  ||| S:693 E:695 ||| .
Participants  ||| S:695 E:708 ||| NNS
were  ||| S:708 E:713 ||| VBD
recruited  ||| S:713 E:723 ||| VBN
by  ||| S:723 E:726 ||| IN
respondent-driven  ||| S:726 E:744 ||| JJ
sampling  ||| S:744 E:753 ||| JJ
methods  ||| S:753 E:761 ||| NNS
( ||| S:761 E:762 ||| -LRB-
RDS ||| S:762 E:765 ||| NNP
) ||| S:765 E:766 ||| -RRB-
,  ||| S:766 E:768 ||| ,
reaching  ||| S:768 E:777 ||| VBG
19  ||| S:777 E:780 ||| CD
waves ||| S:780 E:785 ||| NNS
.  ||| S:785 E:787 ||| .
Trained  ||| S:787 E:795 ||| JJ
staff  ||| S:795 E:801 ||| NN
administered  ||| S:801 E:814 ||| VBN
the  ||| S:814 E:818 ||| DT
socio-behavioural  ||| S:818 E:836 ||| JJ
survey  ||| S:836 E:843 ||| NN
and  ||| S:843 E:847 ||| CC
HIV  ||| S:847 E:851 ||| NNP
and  ||| S:851 E:855 ||| CC
syphilis  ||| S:855 E:864 ||| JJ
voluntary  ||| S:864 E:874 ||| JJ
counselling  ||| S:874 E:886 ||| NN
and  ||| S:886 E:890 ||| CC
testing ||| S:890 E:897 ||| NN
.  ||| S:897 E:899 ||| .
Crude  ||| S:899 E:905 ||| NNP
HIV  ||| S:905 E:909 ||| NNP
and  ||| S:909 E:913 ||| CC
syphilis  ||| S:913 E:922 ||| JJ
prevalence  ||| S:922 E:933 ||| JJ
estimates  ||| S:933 E:943 ||| NNS
were  ||| S:943 E:948 ||| VBD
15.4 ||| S:948 E:952 ||| CD
%  ||| S:952 E:954 ||| NN
( ||| S:954 E:955 ||| -LRB-
RDS-weighted  ||| S:955 E:968 ||| NNP
12.5 ||| S:968 E:972 ||| CD
% ||| S:972 E:973 ||| NN
,  ||| S:973 E:975 ||| ,
95 ||| S:975 E:977 ||| CD
%  ||| S:977 E:979 ||| NN
confidence  ||| S:979 E:990 ||| NN
interval  ||| S:990 E:999 ||| NNS
( ||| S:999 E:1000 ||| -LRB-
CI ||| S:1000 E:1002 ||| NNP
) ||| S:1002 E:1003 ||| -RRB-
:  ||| S:1003 E:1005 ||| :
7.3-17.8 ||| S:1005 E:1013 ||| CD
)  ||| S:1013 E:1015 ||| -RRB-
and  ||| S:1015 E:1019 ||| CC
5.3 ||| S:1019 E:1022 ||| CD
%  ||| S:1022 E:1024 ||| NN
( ||| S:1024 E:1025 ||| -LRB-
RDS-weighted  ||| S:1025 E:1038 ||| NNP
4.4 ||| S:1038 E:1041 ||| CD
% ||| S:1041 E:1042 ||| NN
,  ||| S:1042 E:1044 ||| ,
95 ||| S:1044 E:1046 ||| CD
%  ||| S:1046 E:1048 ||| NN
CI ||| S:1048 E:1050 ||| NNP
:  ||| S:1050 E:1052 ||| :
3.1-7.6 ||| S:1052 E:1059 ||| CD
) ||| S:1059 E:1060 ||| -RRB-
,  ||| S:1060 E:1062 ||| ,
respectively ||| S:1062 E:1074 ||| RB
.  ||| S:1074 E:1076 ||| .
Ninety  ||| S:1076 E:1083 ||| FW
per  ||| S:1083 E:1087 ||| FW
cent  ||| S:1087 E:1092 ||| FW
( ||| S:1092 E:1093 ||| -LRB-
90.4 ||| S:1093 E:1097 ||| NNP
% ||| S:1097 E:1098 ||| NN
,  ||| S:1098 E:1100 ||| ,
unweighted ||| S:1100 E:1110 ||| CD
)  ||| S:1110 E:1112 ||| -RRB-
of  ||| S:1112 E:1115 ||| IN
HIV  ||| S:1115 E:1119 ||| NNP
infections  ||| S:1119 E:1130 ||| NNS
were  ||| S:1130 E:1135 ||| VBD
reported  ||| S:1135 E:1144 ||| VBN
as  ||| S:1144 E:1147 ||| IN
being  ||| S:1147 E:1153 ||| VBG
previously  ||| S:1153 E:1164 ||| RB
undiagnosed ||| S:1164 E:1175 ||| VBN
.  ||| S:1175 E:1177 ||| .
Participants  ||| S:1177 E:1190 ||| NNS
were  ||| S:1190 E:1195 ||| VBD
predominantly  ||| S:1195 E:1209 ||| RB
gay-identified  ||| S:1209 E:1224 ||| JJ
( ||| S:1224 E:1225 ||| -LRB-
60.8 ||| S:1225 E:1229 ||| NNP
% ||| S:1229 E:1230 ||| NN
)  ||| S:1230 E:1232 ||| -RRB-
or  ||| S:1232 E:1235 ||| CC
bisexually  ||| S:1235 E:1246 ||| VB
identified  ||| S:1246 E:1257 ||| VBN
( ||| S:1257 E:1258 ||| -LRB-
36.3 ||| S:1258 E:1262 ||| CD
% ||| S:1262 E:1263 ||| NN
) ||| S:1263 E:1264 ||| -RRB-
;  ||| S:1264 E:1266 ||| :
50.7 ||| S:1266 E:1270 ||| CD
%  ||| S:1270 E:1272 ||| NN
reported  ||| S:1272 E:1281 ||| VBD
recent  ||| S:1281 E:1288 ||| JJ
concurrent  ||| S:1288 E:1299 ||| JJ
relationships ||| S:1299 E:1312 ||| NNS
.  ||| S:1312 E:1314 ||| .
Approximately  ||| S:1314 E:1328 ||| RB
half  ||| S:1328 E:1333 ||| RB
reported  ||| S:1333 E:1342 ||| VBD
consistent  ||| S:1342 E:1353 ||| JJ
condom  ||| S:1353 E:1360 ||| NN
use  ||| S:1360 E:1364 ||| NN
( ||| S:1364 E:1365 ||| -LRB-
always  ||| S:1365 E:1372 ||| RB
or  ||| S:1372 E:1375 ||| CC
almost  ||| S:1375 E:1382 ||| RB
always ||| S:1382 E:1388 ||| RB
)  ||| S:1388 E:1390 ||| -RRB-
with  ||| S:1390 E:1395 ||| IN
casual  ||| S:1395 E:1402 ||| JJ
male  ||| S:1402 E:1407 ||| JJ
partners ||| S:1407 E:1415 ||| NNS
,  ||| S:1415 E:1417 ||| ,
and  ||| S:1417 E:1421 ||| CC
proportions  ||| S:1421 E:1433 ||| NNS
were  ||| S:1433 E:1438 ||| VBD
relatively  ||| S:1438 E:1449 ||| RB
uniform  ||| S:1449 E:1457 ||| JJ
across  ||| S:1457 E:1464 ||| IN
partner  ||| S:1464 E:1472 ||| NN
types  ||| S:1472 E:1478 ||| NNS
and  ||| S:1478 E:1482 ||| CC
genders ||| S:1482 E:1489 ||| NN
.  ||| S:1489 E:1491 ||| .
The  ||| S:1491 E:1495 ||| DT
prevalence  ||| S:1495 E:1506 ||| NN
of  ||| S:1506 E:1509 ||| IN
perceived  ||| S:1509 E:1519 ||| VBN
and  ||| S:1519 E:1523 ||| CC
experienced  ||| S:1523 E:1535 ||| JJ
stigma  ||| S:1535 E:1542 ||| NN
exceeded  ||| S:1542 E:1551 ||| VBD
20 ||| S:1551 E:1553 ||| CD
%  ||| S:1553 E:1555 ||| NN
for  ||| S:1555 E:1559 ||| IN
almost  ||| S:1559 E:1566 ||| RB
all  ||| S:1566 E:1570 ||| DT
variables ||| S:1570 E:1579 ||| NNS
,  ||| S:1579 E:1581 ||| ,
11.4 ||| S:1581 E:1585 ||| CD
%  ||| S:1585 E:1587 ||| NN
ever  ||| S:1587 E:1592 ||| RB
experienced  ||| S:1592 E:1604 ||| VBN
physical  ||| S:1604 E:1613 ||| JJ
violence  ||| S:1613 E:1622 ||| NN
and  ||| S:1622 E:1626 ||| CC
7 ||| S:1626 E:1627 ||| CD
%  ||| S:1627 E:1629 ||| NN
were  ||| S:1629 E:1634 ||| VBD
ever  ||| S:1634 E:1639 ||| RB
raped ||| S:1639 E:1644 ||| VBN
.  ||| S:1644 E:1646 ||| .
Current  ||| S:1646 E:1654 ||| JJ
age  ||| S:1654 E:1658 ||| NN
> ||| S:1658 E:1659 ||| CD
25  ||| S:1659 E:1662 ||| CD
years  ||| S:1662 E:1668 ||| NNS
( ||| S:1668 E:1669 ||| -LRB-
RDS-weighted  ||| S:1669 E:1682 ||| JJ
adjusted  ||| S:1682 E:1691 ||| JJ
odds  ||| S:1691 E:1696 ||| NNS
ratio  ||| S:1696 E:1702 ||| NN
( ||| S:1702 E:1703 ||| -LRB-
AOR ||| S:1703 E:1706 ||| NNP
)  ||| S:1706 E:1708 ||| -RRB-
3.9 ||| S:1708 E:1711 ||| CD
,  ||| S:1711 E:1713 ||| ,
95 ||| S:1713 E:1715 ||| CD
%  ||| S:1715 E:1717 ||| NN
CI ||| S:1717 E:1719 ||| NNP
:  ||| S:1719 E:1721 ||| :
1.2-12.7 ||| S:1721 E:1729 ||| CD
) ||| S:1729 E:1730 ||| -RRB-
,  ||| S:1730 E:1732 ||| ,
single  ||| S:1732 E:1739 ||| JJ
marital  ||| S:1739 E:1747 ||| JJ
status  ||| S:1747 E:1754 ||| NN
( ||| S:1754 E:1755 ||| -LRB-
RDS-weighted  ||| S:1755 E:1768 ||| NNP
AOR ||| S:1768 E:1771 ||| NNP
:  ||| S:1771 E:1773 ||| :
0.3 ||| S:1773 E:1776 ||| CD
;  ||| S:1776 E:1778 ||| :
95 ||| S:1778 E:1780 ||| CD
%  ||| S:1780 E:1782 ||| NN
CI ||| S:1782 E:1784 ||| NNP
:  ||| S:1784 E:1786 ||| :
0.1-0.8 ||| S:1786 E:1793 ||| CD
)  ||| S:1793 E:1795 ||| -RRB-
and  ||| S:1795 E:1799 ||| CC
age  ||| S:1799 E:1803 ||| NN
of  ||| S:1803 E:1806 ||| IN
first  ||| S:1806 E:1812 ||| JJ
sex  ||| S:1812 E:1816 ||| NN
with  ||| S:1816 E:1821 ||| IN
a  ||| S:1821 E:1823 ||| DT
man  ||| S:1823 E:1827 ||| NN
< ||| S:1827 E:1828 ||| SYM
16  ||| S:1828 E:1831 ||| CD
years  ||| S:1831 E:1837 ||| NNS
( ||| S:1837 E:1838 ||| -LRB-
RDS-weighted  ||| S:1838 E:1851 ||| NNP
AOR ||| S:1851 E:1854 ||| NNP
:  ||| S:1854 E:1856 ||| :
4.3 ||| S:1856 E:1859 ||| CD
,  ||| S:1859 E:1861 ||| ,
95 ||| S:1861 E:1863 ||| CD
%  ||| S:1863 E:1865 ||| NN
CI ||| S:1865 E:1867 ||| NNP
:  ||| S:1867 E:1869 ||| :
1.2-15.0 ||| S:1869 E:1877 ||| CD
)  ||| S:1877 E:1879 ||| -RRB-
were  ||| S:1879 E:1884 ||| VBD
independently  ||| S:1884 E:1898 ||| RB
associated  ||| S:1898 E:1909 ||| VBN
with  ||| S:1909 E:1914 ||| IN
HIV  ||| S:1914 E:1918 ||| NNP
infection ||| S:1918 E:1927 ||| NN
.  ||| S:1927 E:1929 ||| .
Results  ||| S:1929 E:1937 ||| NNS
demonstrate  ||| S:1937 E:1949 ||| VBP
that  ||| S:1949 E:1954 ||| IN
MSM  ||| S:1954 E:1958 ||| NNP
represent  ||| S:1958 E:1968 ||| VBP
an  ||| S:1968 E:1971 ||| DT
underserved ||| S:1971 E:1982 ||| NN
,  ||| S:1982 E:1984 ||| ,
at-risk  ||| S:1984 E:1992 ||| JJ
population  ||| S:1992 E:2003 ||| NN
for  ||| S:2003 E:2007 ||| IN
HIV  ||| S:2007 E:2011 ||| NNP
services  ||| S:2011 E:2020 ||| NNS
in  ||| S:2020 E:2023 ||| IN
Malawi  ||| S:2023 E:2030 ||| NNP
and  ||| S:2030 E:2034 ||| CC
merit  ||| S:2034 E:2040 ||| VB
comprehensive  ||| S:2040 E:2054 ||| JJ
HIV  ||| S:2054 E:2058 ||| NNP
prevention  ||| S:2058 E:2069 ||| NN
services ||| S:2069 E:2077 ||| NNS
.  ||| S:2077 E:2079 ||| .
Results  ||| S:2079 E:2087 ||| NNS
provide  ||| S:2087 E:2095 ||| VBP
a  ||| S:2095 E:2097 ||| DT
number  ||| S:2097 E:2104 ||| NN
of  ||| S:2104 E:2107 ||| IN
priorities  ||| S:2107 E:2118 ||| NNS
for  ||| S:2118 E:2122 ||| IN
research  ||| S:2122 E:2131 ||| NN
and  ||| S:2131 E:2135 ||| CC
prevention  ||| S:2135 E:2146 ||| NN
programmes  ||| S:2146 E:2157 ||| NN
for  ||| S:2157 E:2161 ||| IN
MSM ||| S:2161 E:2164 ||| NNP
,  ||| S:2164 E:2166 ||| ,
including  ||| S:2166 E:2176 ||| VBG
providing  ||| S:2176 E:2186 ||| VBG
access  ||| S:2186 E:2193 ||| NN
to  ||| S:2193 E:2196 ||| TO
and  ||| S:2196 E:2200 ||| CC
encouraging  ||| S:2200 E:2212 ||| VBG
regular  ||| S:2212 E:2220 ||| JJ
confidential  ||| S:2220 E:2233 ||| JJ
HIV  ||| S:2233 E:2237 ||| NNP
testing  ||| S:2237 E:2245 ||| NN
and  ||| S:2245 E:2249 ||| CC
counselling ||| S:2249 E:2260 ||| NN
,  ||| S:2260 E:2262 ||| ,
and  ||| S:2262 E:2266 ||| CC
risk  ||| S:2266 E:2271 ||| NN
reduction  ||| S:2271 E:2281 ||| NN
counselling  ||| S:2281 E:2293 ||| VBZ
related  ||| S:2293 E:2301 ||| VBN
to  ||| S:2301 E:2304 ||| TO
anal  ||| S:2304 E:2309 ||| VB
intercourse ||| S:2309 E:2320 ||| NNS
.  ||| S:2320 E:2322 ||| .
Other  ||| S:2322 E:2328 ||| JJ
targets  ||| S:2328 E:2336 ||| NNS
include  ||| S:2336 E:2344 ||| VBP
the  ||| S:2344 E:2348 ||| DT
provision  ||| S:2348 E:2358 ||| NN
of  ||| S:2358 E:2361 ||| IN
condoms  ||| S:2361 E:2369 ||| NNS
and  ||| S:2369 E:2373 ||| CC
compatible  ||| S:2373 E:2384 ||| JJ
lubricants ||| S:2384 E:2394 ||| NNS
,  ||| S:2394 E:2396 ||| ,
HIV  ||| S:2396 E:2400 ||| NNP
prevention  ||| S:2400 E:2411 ||| NN
information ||| S:2411 E:2422 ||| NN
,  ||| S:2422 E:2424 ||| ,
and  ||| S:2424 E:2428 ||| CC
HIV  ||| S:2428 E:2432 ||| NNP
and  ||| S:2432 E:2436 ||| CC
sexually  ||| S:2436 E:2445 ||| RB
transmitted  ||| S:2445 E:2457 ||| JJ
infection  ||| S:2457 E:2467 ||| NN
treatment  ||| S:2467 E:2477 ||| NN
and  ||| S:2477 E:2481 ||| CC
adherence  ||| S:2481 E:2491 ||| JJ
support ||| S:2491 E:2498 ||| NN
.  ||| S:2498 E:2500 ||| .
Addressing  ||| S:2500 E:2511 ||| VBG
multiple  ||| S:2511 E:2520 ||| JJ
levels  ||| S:2520 E:2527 ||| NNS
of  ||| S:2527 E:2530 ||| IN
HIV  ||| S:2530 E:2534 ||| NNP
risk ||| S:2534 E:2538 ||| NN
,  ||| S:2538 E:2540 ||| ,
including  ||| S:2540 E:2550 ||| VBG
structural  ||| S:2550 E:2561 ||| JJ
factors ||| S:2561 E:2568 ||| NNS
,  ||| S:2568 E:2570 ||| ,
may  ||| S:2570 E:2574 ||| MD
help  ||| S:2574 E:2579 ||| VB
to  ||| S:2579 E:2582 ||| TO
ensure  ||| S:2582 E:2589 ||| VB
that  ||| S:2589 E:2594 ||| IN
programmes  ||| S:2594 E:2605 ||| NNS
have  ||| S:2605 E:2610 ||| VBP
sufficient  ||| S:2610 E:2621 ||| JJ
coverage  ||| S:2621 E:2630 ||| NN
to  ||| S:2630 E:2633 ||| TO
impact  ||| S:2633 E:2640 ||| VB
this  ||| S:2640 E:2645 ||| DT
HIV  ||| S:2645 E:2649 ||| NNP
epidemic  ||| S:2649 E:2658 ||| NN
among  ||| S:2658 E:2664 ||| IN
MSM ||| S:2664 E:2667 ||| NNP
.  ||| S:2667 E:2669 ||| .
